EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR

Yeon-Sook Kim iD, Jun Yong Choi iD, Dae Won Park iD, Shin-Woo Kim iD, Tae Hyong Kim iD, Julie Ryu iD, Rebecca Harrison iD, Jeong-A Lee iD, Flora Park iD, Sun Hee Lee iD

Infection & Chemotherapy · 2025 · 57 (3) · 424

DOI: 10.3947/ic.2025.0061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection & Chemotherapy, 2025. Verfasst von Yeon-Sook Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AsiaBictegravirCombination antiretroviral therapyKoreaObservational study

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.
  • Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
  • Division of Infectious Diseases, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
  • Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Gilead Sciences, Inc., Foster City, CA, USA.

ORCID-Profile: Yeon-Sook Kim, Jun Yong Choi, Dae Won Park, Shin-Woo Kim, Tae Hyong Kim, Julie Ryu, Rebecca Harrison, Jeong-A Lee, Flora Park, Sun Hee Lee

Förderung

  • Gilead Sciences

Zitieren

APA

Kim, Y. S., Choi, J. Y., Park, D. W., Kim, S. W., Kim, T. H., Ryu, J., Harrison, R., Lee, J. A., Park, F., & Lee, S. H. (2025). Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR. Infection & Chemotherapy, 57(3), 424. https://doi.org/10.3947/ic.2025.0061

Vancouver

Kim YS, Choi JY, Park DW, Kim SW, Kim TH, Ryu J, et al. Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR. Infection & Chemotherapy. 2025;57(3):424. doi:10.3947/ic.2025.0061

BibTeX
@article{Kim2025,
  author = {Kim, Yeon-Sook and Choi, Jun Yong and Park, Dae Won and Kim, Shin-Woo and Kim, Tae Hyong and Ryu, Julie and Harrison, Rebecca and Lee, Jeong-A and Park, Flora and Lee, Sun Hee},
  title = {Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV in Korea: 24-Month Data from BICSTaR},
  journal = {Infection & Chemotherapy},
  year = {2025},
  volume = {57},
  number = {3},
  pages = {424},
  doi = {10.3947/ic.2025.0061}
}
Kostenlos starten →